DrugCard
PrivateLast Round
Seed
Aug 22, 2023
Total Funding Raised
$288,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DrugCard is a health tech company that provides an AI-powered pharmacovigilance platform for automated medical literature screening and drug safety monitoring.
Sector
Healthcare & Life Sciences
Verticals
Compliance & Risk, Medical AI, RegTech, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DrugCard Comparables
Compare DrugCard with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| biologit | 91% | |
| PubHive Ltd. | 86% | |
| Datafoundry | 85% | |
DrugCard Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 22, 2023 | ||||
| Seed | Dec 9, 2021 |
Key People
Founding team and executive leadership
DrugCard Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Demium Capital | Seed |
| New Nordic Venture | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 51% MoM.
- May 22, 2026
Grew 26% QoQ, from 19 to 24 employees.
DrugCard Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DrugCard's valuation, stock price, and market status.